Here are a few of the most interesting Illumina statistics and facts I was able to dig up. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available. Please note that some of these numbers are easier to find than others. A few of these Illumina stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don\u2019t guarantee anything to be 100% Illumina Facts \tIllumina Website: www.illumina.com \tYear Illumina was Founded: 1998 \tIllumina Headquarters:\u00a0 San Diego, CA \tIllumina Founders: David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik and Mark Chee \tIllumina CEO: Francis deSouza Illumina Statistics Number of Illumina employees: 7,700 employees Last updated 1\/1\/20 Number of Illumina patents: 799 issued US patents and 617 pending US patent applications Last updated 1\/16\/20 Illumina revenue (annual): \t2019: $3.543 billion \t2018: $3.333 billion \t2017:\u00a0$2.752 billion \t2016:\u00a0$2.398 billion \t2015:\u00a0$2.220 billion Illumina net income (annual): \t2019: $990 million \t2018: $782 million \t2017:\u00a0$678 million \t2016:\u00a0$428 million \t2015: $458 million \tThis full report is available in an annual industry report. Some of the data in industry reports include: Company Quick Facts Employee Counts Income and Revenue Totals Etc.-\u00a0all in one place I try to go through each and every stat regularly and update as much as possible, but we all know that some stats are easier to track down than others. As always, every stat is linked to its original source and has the source date listed. To get your copy of the report, click on the button below to purchase it. Report 1:\u00a0 Biopharma Industry Report ( Abbott, Abbvie, Allergan, Amgen, Astellas, AstraZeneca, Bayer, Biogen, Bristol-Myers Squibb, Eli Lilly, Gilead, GlaxoSmithKline, Illumina, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Stryker, Takeda, Vertex and Zoetis).